Search Results

1-20 of 241 results for subject:Prices

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Trade and Industry, pursuant to his Answer of 16th February, 325 c661-2W, concerning petrol prices and petrol taxation in member countries of the European Union, if he will update those figures. - Inc table and ref to 325 c661-2W, 16 February 1999.

Asked by

Lord Boswell of Aynho (Conservative)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Tabled on

8 November 1999

For answer on

11 November 1999

Answered on

11 November 1999

Mr. Boswell: To ask the Secretary of State for Trade and Industry, pursuant to his answer of 16 February 1999, Official Report, column 664, concerning petrol prices and petrol taxation in member countries of the European Union, if he will update those figures. [98107] Mrs. Liddell: The latest figures for unleaded petrol prices are for mid-September 1999. The information requested is as follows: _________________________________________________________________________________________________. Average price (pence per litre) Total Of which: taxes % of tax United Kingdom 73.0 58.1 79.5 Austria 54.6 35.8 65.7 Belgium 60.3 43.2 71.7 Denmark 63.6 45.5 71.6 Finland 68.4 48.5 70.9 France 63.9 49.0 76.7 Germany 60.1 42.7 70.9 Greece 43.6 26.3 60.3 Ireland 50.5 33.2 65.8 Italy 64.3 45.7 71.1 Luxembourg 47.1 29.1 61.8 Netherlands 66.9 47.9 71.6 Portugal 51.9 33.9 65.4 Spain 47.6 30.6 64.2 Sweden 65.3 46.2 70.9 _________________________________________________________________________________________________. Comparisons between these figures and those for December 1998, published in the answer of 16 February 1999, Official Report, column 664, are affected by exchange rate movements over the period.

Date

11 November 1999

Reference

98107; 337 c716W

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, what the terms of reference are for the Director General of Fair Trading's review of petrol undertakings; when the review will be completed; and if he will make a statement.

Asked by

Baroness Browning (Conservative)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

11 November 1999

Reference

98233; 337 c716-7W

House

House of Commons

Northern Ireland Office

To ask the Secretary of State for Northern Ireland, what was the average price paid in (a) September and (b) October, in 1999, 1998, 1997, 1996, 1995, 1990 and 1985 in (i) cash and (ii) real terms, for suckler calves in the principal markets for such stock in Northern Ireland....

Asked by

William Ross (Ulster Unionist Party)

Answering body

Northern Ireland Office

Type

Written questions

Status

Answered

Tabled on

4 November 1999

For answer on

11 November 1999

Answered on

11 November 1999

Mr. William Ross: To ask the Secretary of State for Northern Ireland what was the average price paid in (a) September and (b) October, in 1999, 1998, 1997, 1996, 1995, 1990 and 1985 in (i) cash and (ii) real terms, for suckler calves in the principal markets for such stock in Northern Ireland. [97825] Mr. George Howarth: [holding answer 9 November 1999]: Estimates of prices paid for suckled calves in a sample of the main markets in Norther Ireland in September and October of the years shown are given in the table, in current prices and in real terms. Prices of suckled calves in Northern Ireland £ per head _________________________________________________________________________________________________. Current prices Prices in Real Terms using September 1999 as the base September October September October 1985 225.20 227.81 392.33 396.19 1990 246.58 282.77 316.94 360.68 1995 {1}-- 436.42 {1}-- 483.84 1996 {1}-- 326.17 {1}-- 352.62 1997 {1}-- 327.77 {1}-- 341.43 1998 143.64 210.79 145.24 212.92 1999 166.83 232.09 166.83 231.86 _________________________________________________________________________________________________. {1} No sales recorded in these months

Date

11 November 1999

Reference

97825; 337 c745W

House

House of Commons

Dept of Trade and Industry

Statement on what was the outcome of the Industry Council held in Brussels on 9th November; and if he will make a statement.

Asked by

Jim Marshall (Labour)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Tabled on

9 November 1999

For answer on

11 November 1999

Answered on

11 November 1999

Mr. Jim Marshall: To ask the Secretary of State for Trade and Industry what was the outcome of the Industry Council held in Brussels on 9 November; and if he will make a statement. [98300] Mrs. Liddell: I represented the UK at the EU Industry Council held on 9 November. The Council agreed its report to the Helsinki European Council on the integration of industry and sustainable development policy. There was also a discussion of Kyoto targets, where there was general agreement that more effective co-ordination was needed on how to take account of industry's concerns in the implementation of Kyoto targets. The Council had a debate on competitiveness, which focused on the need for structural change and adaptability in European industry, the importance of SMEs and the role of information and communication technologies in growth and competitiveness. The Commission presented its first market monitoring report on the world shipbuilding market which highlighted both the serious situation in the market and further clear evidence of unfair pricing by Korea. The Council with strong support from the UK emphasised its serious concern at the situation and unfair pricing from Korea and in its conclusions made clear its determination to tackle such unfair trade practices and agreed further action to this end. The Council called on the Commission and the Presidency to re-engage Korea in bilateral consultations with a view to halting the unfair competition and in parallel urged Industry, member states and the Commission to seek more detailed evidence in order to take appropriate action under the WTO. The Council also emphasised the need to continue to ensure that the conditions of the IMF rescue package were fully respected. The Council ended its conclusions by welcoming the Commission's determination to continue to pursue its obligations under the EU shipbuilding regime and to report on developments as soon as possible. The new Commission's enterprise policy was set out and focused on promoting entrepreneurship and innovation in Europe, stimulating the growth of SMEs, tackling red tape, addressing failures in the provision of risk capital and promoting an inclusive and cohesive Information Society. The Commission stated that it wanted to see a new innovation policy process which would involve assessing the existing situation in Europe, identifying specific priorities and actions and reporting on measures taken by member states. A number of delegations stressed the importance of investment in intangibles, particularly the knowledge base, training and life-long learning; the increased use of information technology; and the consolidation of Councils. On the latter, there was support from a number of member states for a more focused approach to competitiveness issues and for merger of the Industry Internal Market Councils as a first step. The Presidency was encouraged to settle issue at the Helsinki European Council. The Commission also presented its: Communication on the competitiveness of the forest based and related industries; Communication on the competitiveness of the steel industry; Report on the monitoring of aid for steel; Action Plan on the competitiveness of the construction industry; and gave a progress report on the public consultation on it's competition policy modernisation proposals. The Danish delegation introduced a paper on state aid policy which highlighted the damage state aid caused to the Single Market. The Council also adopted conclusions on the competitiveness of the forest-based and related industries.

Date

11 November 1999

Reference

98300; 337 c729-30W

House

House of Commons

Treasury

To ask Mr Chancellor of the Exchequer, If he will make a statement on the change in price competitiveness of British exports since May 1997. (Failed OPQ).

Asked by

Vincent Cable (Liberal Democrat)

Answering body

Treasury

Type

Written questions

Status

Answered

Date

11 November 1999

Reference

97007; 337 c765W

House

House of Commons

Price Marking Order 1999

SI 1999/3042 (Negative instrument). Coming into force for Article 2(1) 4 December 1999 and for the remainder 18 March 2000

Department

Department of Trade and Industry

Type

Statutory instruments

Date

11 November 1999

Reference

SI 1999/3042

House

House of Commons; House of Lords

Dept of Health

To ask the Secretary of State for Health, if he will list (a) for each of the last five years the amount the NHS has paid, and (b) the amount it expects to pay in this financial year, for the drug thyroxine; what the unit price was, or is, in...

Asked by

Harry Cohen (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

26 October 1999

For answer on

10 November 1999

Answered on

10 November 1999

Mr. Cohen: To ask the Secretary of State for Health if he will list (a) for each of the last five years the amount the NHS has paid, and (b) the amount it expects to pay in this financial year, for the drug thyroxine; what the unit price was, or is, in each of those years; and what reasons underlay the changes. [96445] Mr. Denham: The data requested are shown in the tables. The amount which the National Health Service pays for any medicine depends on the total quantity prescribed and the price. In the case of thyroxine, the quantity prescribed generically has increased in recent years and during this one. As regards price, the price which the NHS pays for thyroxine, as for other generic medicines, is based on prices which are set by competition in the market place. It is not controlled by government. There has been a spate of shortages of generic medicines during 1999 which have led to price rises, some of which have been dramatic. The increases in the prices of thyroxine tablets have been at the upper end of this range. The total cost of thyroxine for the rest of the financial year will depend on price and volume trends in the coming months. The net ingredient cost for thyroxine sodium preparations dispensed in the community, 1994 to 1998, and 1999 (January to June) England £000 _________________________________________________________________________________________________. Drug name 1994 1995 1996 1997 1998 1999 Eltroxin Tab 50mcg 53.0 46.9 42.1 54.6 48.8 21.8 Eltroxin Tab 100mcg 45.3 39.9 36.0 41.7 37.8 17.4 Thyroxine Sod Tab 100mcg 341.9 338.1 350.8 456.7 992.6 3,739.6 Thyroxine Sod Tab 50mcg 402.7 392.9 405.4 548.7 1,088.7 2,637.4 Thyroxine Sod Tab 25mcg 457.2 625.4 1,069.3 1,404.5 1,668.9 1,536.2 Thyroxine Sod Oral Liq 11.1 -- -- -- -- -- @spec Thyroxine Sod Liq Spec -- 2.7 3.3 -- -- -- 75mcg/5ml Thyroxine Sod Liq Spec -- 9.5 11.9 18.7 18.2 13.1 50mcg/5ml Thyroxine Sod Liq Spec -- 5.1 9.6 10.4 18.1 11.2 100mcg/5ml Thyroxine Sod Liq Spec -- 4.5 5.1 7.2 11.7 5.1 125mcg/5ml Thyroxine Sod Liq Spec -- 5.2 4.9 6.9 7.9 3.2 25mcg/5ml Thyroxine Sod Liq Spec -- -- -- 1.8 2.0 -- 150mcg/5ml Thyroxine Sod Liq Spec -- -- -- 2.8 2.7 -- 250mcg/5ml Thyroxine Sod Liq Spec -- -- -- 1.9 -- -- 200mcg/5ml Total 1,324.7 1,482.7 1,958.1 2,579.9 3,931.8 8,014.8 _________________________________________________________________________________________________. Notes: 1. The data cover all prescriptions dispensed in the community, ie by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. 2. The net ingredient cost is the basic cost of a drug and does not take account of discounts, dispensing costs, fees or prescription charges income. 3. For reasons of confidentiality, any individual preparation where less than 50 prescription items were dispensed is excluded. However the total includes all preparations dispensed. The net ingredient cost per quantity for thyroxine sodium preparations dispensed in the community, 1994 to 1998, and 1999 (January to June) England £ _________________________________________________________________________________________________. Drug name 1994 1995 1996 1997 1998 1999 Eltroxin Tab 50mcg 0.004 0.004 0.004 0.005 0.006 0.006 Eltroxin Tab 100mcg 0.005 0.005 0.005 0.006 0.006 0.006 Thyroxine Sod Tab 100mcg 0.003 0.002 0.002 0.003 0.006 0.042 Thyroxine Sod Tab 50mcg 0.002 0.002 0.002 0.003 0.005 0.025 Thyroxine Sod Tab 25mcg 0.009 0.010 0.014 0.016 0.016 0.027 Thyroxine Sod Oral Liq 0.275 -- -- -- -- -- @spec Thyroxine Sod Liq Spec -- 0.176 0.260 -- -- -- 75mcg/5ml Thyroxine Sod Liq Spec -- 0.294 0.287 0.305 0.223 0.240 50mcg/5ml Thyroxine Sod Liq Spec -- 0.301 0.234 0.249 0.272 0.280 100mcg/5ml Thyroxine Sod Liq Spec -- 0.607 0.418 0.352 0.482 0.507 125mcg/5ml Thyroxine Sod Liq Spec -- 0.226 0.175 0.195 0.228 0.313 25mcg/5ml Thyroxine Sod Liq Spec -- -- -- 0.219 0.257 -- 150mcg/5ml Thyroxine Sod Liq Spec -- -- -- 0.752 0.705 -- 250mcg/5ml Thyroxine Sod Liq Spec -- -- -- 0.298 -- -- 200mcg/5ml _________________________________________________________________________________________________. Notes: 1. The data cover all prescriptions dispensed in the community, ie by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. 2. The net ingredient cost is the basic cost of a drug and does not take account of discounts, dispensing costs, fees or prescription charges income. 3. The quantity of the drug dispensed is measured in units depending on the formulation of the product, for example one tablet or one millilitre. 4. The net ingredient cost per quantity figure is the average over each period and will reflect any price changes in the period.

Date

10 November 1999

Reference

96445; 337 c650-2W;337 c650-1W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what data his Department has collated from the English health authorities as to the impact on their drugs budgets of the recent shortages and rising prices of generic drugs over the last 12 months; and if he will publish such information as...

Asked by

Peter Bradley (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

10 November 1999

Reference

337 c649-50W; 96171;96172

House

House of Commons

McIntosh of Haringey, Lord

What representations were made by J Sainsbury plc to the Department of Trade and Industry investigation into supermarket and retail pricing. [HL 4386].

Asked by

Lord Brougham and Vaux (Conservative)

Type

Written questions

Status

Answered

Date

10 November 1999

Reference

HL 4386; 606 c184WA

House

House of Lords

Home Office

To ask the Secretary of State for the Home Department, if the textile, clothing and footwear produced within HM Prisons is sold at normal commercial prices for goods of comparable quality; and what measures are in place to ensure that this is done.

Asked by

Judy Mallaber (Labour)

Answering body

Home Office

Type

Written questions

Status

Answered

Date

9 November 1999

Reference

97959; 337 c470W

House

House of Commons

Lords debate on unstarred question on how their proposals for the milk industry and in particular for the supply of raw milk will affect the rural economy

Lords debate on unstarred question on how their proposals for the milk industry and in particular for the supply of raw milk will affect the rural economy.

Lead member

Lord Grantchester

Answering member

Lord Carter

Type

Questions for short debate

Date

9 November 1999

Reference

606 c1305-22

House

House of Lords

Dept of Health

To ask the Secretary of State for Health, what is the (a) actual and (b) percentage increase in the price of generic drugs to the NHS over the last 12 months. - Inc table.

Asked by

Louise Ellman (Labour; Co-operative Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

2 November 1999

For answer on

8 November 1999

Answered on

8 November 1999

Mrs. Ellman: To ask the Secretary of State for Health what is the (a) actual and (b) percentage increase in the price of generic drugs to the NHS over the last 12 months. [97293] Mr. Denham: An index of Drug Tariff prices for the top 100 generic drugs dispensed in 1998 (by net ingredient cost) for this year is as follows: _________________________________________________________________________________________________. Month Index January 100.0 April 103.4 May 106.5 June 112.0 July 117.0 August 124.4 September 126.2 October 130.7 November 132.9 _________________________________________________________________________________________________. It has been possible to provide only 11 months' data.

Date

8 November 1999

Reference

97293; 337 c455W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what was the change in the drug tariff to the NHS for 1,000 thyroxin 100 mcg in actual and percentage terms between November 1998 and November 1999. - Inc figures

Asked by

Louise Ellman (Labour; Co-operative Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

8 November 1999

Reference

97291; 337 c455-6W

House

House of Commons

Ministry of Agriculture Fisheries and Food

To ask the Minister of Agriculture, Fisheries and Food, what plans he has for further discussions with supermarket chains on pricing policy; and what progress he has made.

Asked by

Jim Dobbin (Labour; Co-operative Party)

Answering body

Ministry of Agriculture Fisheries and Food

Type

Written questions

Status

Answered

Date

8 November 1999

Reference

96683; 337 c461-2W

House

House of Commons

Falconer of Thoroton, Lord

Answered by

Lord Falconer of Thoroton (Labour)

Type

Oral answers to questions

Date

8 November 1999

Reference

606 c1147-8

House

House of Lords

Falconer of Thoroton, Lord

What measures they have taken to ensure that Govt depts are taking advantage of the low prices available in the United Kingdom for internal and overseas telephone calls.

Asked by

Lord Jacobs (Liberal Democrat)

Oral questions - Lead

Status

Answered

Date

8 November 1999

Reference

606 c1147-8

House

House of Lords

Audit of the future oil price convention for the November 1999 pre-Budget report. Report by the Comptroller and Auditor General.

Type

House of Commons papers

Notes

Received 08.11.99; Received 02.12.98

Date

8 November 1999

Reference

HC 873 1998/99

House

House of Commons

SUPERMARKETS AND BRITISH AGRICULTURE

That this House notes with dismay the growing gap between farm gate prices and increasing supermarket profits; urges the food retail sector to recognise its vital contribution in ensuring a long-term sustainable future for Britain's agricultural producers; condemns the continuing cost of Government regulations and the dominant power of the...

Primary sponsor

Colin Breed (Liberal Democrat)

Type

Early day motions

Date

5 November 1999

Reference

992

House

House of Commons

Lords debate on motion to take note of the twelfth report of the European Communities Committee on Electricity from Renewables

Lords debate on motion to take note of the twelfth report of the European Communities Committee on Electricity from Renewables. (HL 78 1998/99).

Lead member

Lord Geddes

Answering member

Baroness Farrington of Ribbleton

Department

Department of the Environment, Transport and the Regions; European Communities Committee

Type

Debates on select committee reports

Date

5 November 1999

Reference

606 c1102-35,1137-46

House

House of Lords

Dept of Health

To ask the Secretary of State for Health, what measures are being taken to ensure that the NHS is able to purchase drugs at the cheapest possible rate. - Includes figures.

Asked by

Baroness King of Bow (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

19 October 1999

For answer on

4 November 1999

Answered on

4 November 1999

Ms Oona King: To ask the Secretary of State for Health what measures are being taken to ensure that the NHS is able to purchase drugs at the cheapest possible rate. [95163] Mr. Hutton: We have a number of measures in place to help ensure that the National Health Service purchases medicines on reasonable terms. The Pharmaceutical Price Regulation Scheme (PPRS) secures the provision of branded medicines at fair prices to the NHS that also reflect the cost of researching and developing these medicines. We have recently negotiated a new PPRS which came into effect on 1 October. This includes a reduction of 4.5 per cent. in list prices of branded medicines, which will save the NHS over £150 million a year. Prices for generic medicines, which are outside the PPRS, are determined by competition in the market. In the past this market has delivered generic medicines at reasonable prices and ensured continuity of supply. Prices, however, have risen sharply this year due at least in part to supply problems. We are concerned that the scale of the rises may be unjustified and are examining every possible option to see how a more normal market situation can be restored. Hospitals buy many medicines by competitive tender, often pooling their purchasing power through the NHS Supplies Authority and may utilise formularies to make choices between medicines of similar properties but differing prices. The arrangements for reimbursing community pharmacies and dispensing doctors for the cost of the medicines they supply contain incentives which encourage them to shop around for the lowest prices, while ensuring that much of the discount which they receive is clawed back. In 1998-99 a total of £400 million was saved in this way.

Date

4 November 1999

Reference

337 c304W; 95163

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher